| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |